The breast cancer cell lines we used to conduct our experiments—namely, MCF-7 and MDA-MB-468—contained a functional CD44+CD24-/low cancer stem cell subpopulation, as per the published literature [59] and our own preliminary experiments had indicated (data not shown). This evidence concerns the gene CD44 and breast cancer.